Event

Back to all webinars

Title: Are Clinical Outcome Assessments Sufficiently Valued?

Wednesday, May 29, 2024
10:00AM EDT | 2:00PM UTC | 4:00PM CEST

Click here for time zone conversion

Register Now

Description

This webinar is for Clinical Outcome Assessment (COA) scientists involved in developing COA strategies to generate evidence for stakeholders such as regulatory bodies, reimbursement agencies, clinicians, and patients. The webinar will also be of benefit to those interested in learning how COA data can be valued by multiple stakeholders. The challenges of developing robust COA strategies that meet the needs of all stakeholders will be discussed. The presenters will discuss the value of COA data from different stakeholder perspectives. The webinar will cover the SISAQOL-IMI perspective and initiatives to ensure scientific integrity and standardization of COA analyses and interpretations, enabling greater value across stakeholders. The webinar will also discuss the challenges of evaluating COA data from an HTA perspective, reflecting the different evidentiary requirements for submissions to different HTA bodies. An industry perspective will be presented on the selection of COAs required to meet the evidence needs of different stakeholders. Additionally, the webinar will cover the evolving landscape of COA evidence requirements from a global regulatory perspective, particularly highlighting the differences between the main regulatory agencies. The aim of the webinar is to increase awareness of the challenges associated with generating COA data and its value to different stakeholders and generate discussion to inform potential solutions to these challenges.

Learning Objectives

• Increase awareness of the complexity in developing COA strategies to meet different stakeholder requirements.
• Develop a greater understanding of the value of COA data from diverse perspectives and identify synergies across the value of COA data among various stakeholders.
• Greater awareness of various initiatives in development to enhance the value of COA data.
  

Speakers:

Bryan Bennett, PhD, Head of Patient-Centered Outcomes, Jazz Pharmaceuticals, Horncliffe, England, UK

Ahu Alanya, PhD, Team Lead EORTC, Quality of Life Group, Brussels, Belgium

Anders Ingelgaard, Industry Representative and Co-Lead, SISAQOL-IMI Consortium, Frankfurt, Germany

Anja Schiel, PhD, Senior Advisor, Norwegian Medicines Agency, Oslo, Norway

Brought to you by: ISPOR Clinical Outcome Assessment Special Interest Group

Please note: On the day of the scheduled webinar, the first 1000 registered participants will be accepted into the webinar. For those who are unable to attend, or would like to review the webinar at a later date, the full-length webinar recording will be made available at the ISPOR Educational Webinar Series webpage approximately 2 days after the scheduled Webinar.